businesspress24.com - Diadexus, Inc. to Report First Quarter 2015 Financial Results on May 12, 2015
 

Diadexus, Inc. to Report First Quarter 2015 Financial Results on May 12, 2015

ID: 1356689

Conference Call and Webcast Scheduled for 4:30 p.m. ET (1:30 p.m. PT)

(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/05/15 -- Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced that it will report first quarter 2015 financial results on Tuesday, May 12, 2015 after market close, and will host a conference call to discuss financial results and provide a business update at 4:30 p.m. ET (1:30 p.m. PT).

To access the webcast, visit the Company''s website at . To access the conference call, dial 1 (855) 666-6874 for domestic callers and (262) 912-6259 for international callers. The reservation number for both is 35808144. A replay of the webcast will be available shortly following the live webcast for a period of four weeks.

Diadexus, based in South San Francisco, California, is a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, providing healthcare providers with actionable information for managing patients. The Company pioneered the testing of Lp-PLA2 (lipoprotein-associated phospholipase A2), a marker of vascular-specific inflammation that provides new information, over and above traditional risk factors measured in a lipid panel, and has over a decade of peer-reviewed literature validating this biomarker''s utility. Diadexus'' products are the only two FDA-cleared tests to measure Lp-PLA2: The PLAC® Test ELISA Kit first cleared by the FDA in 2003 and The PLAC® Test for Lp-PLA2 Activity cleared in December 2014.

The Company also has a pipeline of biomarkers for heart failure, proADM, proET-1 and proANP, with each providing distinct, additive information for healthcare providers over currently available markers. Diadexus also provides services to pharmaceutical partners to address the need to incorporate biomarkers in clinical development. For more information, please visit the Company''s website at .



CONTACT:
Amy Figueroa, CFA




650-246-6424
Investor Relations and Corporate Communications


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Inogen, Inc.
A quiet approach: Airbus Helicopters demonstrates low-noise IFR operations at airport with commercial traffic
Bereitgestellt von Benutzer: Marketwired
Datum: 05.05.2015 - 14:05 Uhr
Sprache: Deutsch
News-ID 1356689
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SOUTH SAN FRANCISCO, CA


Phone:

Kategorie:

Equipment & Supplies


Anmerkungen:


Diese Pressemitteilung wurde bisher 281 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Diadexus, Inc. to Report First Quarter 2015 Financial Results on May 12, 2015
"
steht unter der journalistisch-redaktionellen Verantwortung von

Diadexus, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Diadexus, Inc.



 

Who is online

All members: 10 562
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 62


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.